506 related articles for article (PubMed ID: 23138460)
1. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Suades R; Padró T; Vilahur G; Badimon L
Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
[TBL] [Abstract][Full Text] [Related]
2. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
[TBL] [Abstract][Full Text] [Related]
3. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
[TBL] [Abstract][Full Text] [Related]
4. Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicity.
Jerez-Dolz D; Torramade-Moix S; Palomo M; Moreno-Castaño A; Lopez-Vilchez I; Hernandez R; Badimon JJ; Zafar MU; Diaz-Ricart M; Escolar G
Atherosclerosis; 2020 Feb; 294():17-24. PubMed ID: 31945614
[TBL] [Abstract][Full Text] [Related]
5. A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall--studies in a porcine model.
Badimon L; Martínez-González J; Royo T; Lassila R; Badimon JJ
Thromb Haemost; 1999 Dec; 82(6):1736-42. PubMed ID: 10613663
[TBL] [Abstract][Full Text] [Related]
6. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
7.
Nijiati M; Saidaming A; Guoqing L
Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
[TBL] [Abstract][Full Text] [Related]
8. Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating blood.
Lopez-Vilchez I; Tonda R; Hernandez RM; Navalon F; Diaz-Ricart M; Galan AM; Escolar G
Coron Artery Dis; 2009 Sep; 20(6):392-9. PubMed ID: 19561489
[TBL] [Abstract][Full Text] [Related]
9. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet deposition on atherosclerotic coronary arteries.
van Zanten GH; de Graaf S; Slootweg PJ; Heijnen HF; Connolly TM; de Groot PG; Sixma JJ
J Clin Invest; 1994 Feb; 93(2):615-32. PubMed ID: 8113399
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
12. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
[TBL] [Abstract][Full Text] [Related]
13. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus.
Hu H; Zhu L; Huang Z; Ji Q; Chatterjee M; Zhang W; Li N
Thromb Haemost; 2010 Dec; 104(6):1184-92. PubMed ID: 20838746
[TBL] [Abstract][Full Text] [Related]
14. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
[TBL] [Abstract][Full Text] [Related]
15. Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients.
Suades R; Padró T; Vilahur G; Martin-Yuste V; Sabaté M; Sans-Roselló J; Sionis A; Badimon L
J Thromb Haemost; 2015 Oct; 13(10):1776-86. PubMed ID: 26239059
[TBL] [Abstract][Full Text] [Related]
16. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi.
Badimon L; Chesebro JH; Badimon JJ
Circulation; 1992 Dec; 86(6 Suppl):III74-85. PubMed ID: 1424053
[TBL] [Abstract][Full Text] [Related]
17. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
18. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
19. The Effects of the Combined Argatroban/Nitric Oxide-Releasing Polymer on Platelet Microparticle-Induced Thrombogenicity in Coated Extracorporeal Circuits.
Bellomo TR; Jeakle MA; Meyerhoff ME; Bartlett RH; Major TC
ASAIO J; 2021 May; 67(5):573-582. PubMed ID: 33902103
[TBL] [Abstract][Full Text] [Related]
20. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
